Bianchini, M.L.; Aquilante, C.L.; Kao, D.P.; Martin, J.L.; Anderson, H.D.
Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database. J. Pers. Med. 2023, 13, 1574.
https://doi.org/10.3390/jpm13111574
AMA Style
Bianchini ML, Aquilante CL, Kao DP, Martin JL, Anderson HD.
Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database. Journal of Personalized Medicine. 2023; 13(11):1574.
https://doi.org/10.3390/jpm13111574
Chicago/Turabian Style
Bianchini, Monica L., Christina L. Aquilante, David P. Kao, James L. Martin, and Heather D. Anderson.
2023. "Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database" Journal of Personalized Medicine 13, no. 11: 1574.
https://doi.org/10.3390/jpm13111574
APA Style
Bianchini, M. L., Aquilante, C. L., Kao, D. P., Martin, J. L., & Anderson, H. D.
(2023). Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database. Journal of Personalized Medicine, 13(11), 1574.
https://doi.org/10.3390/jpm13111574